ENANTA PHARMACEUTICALS INC
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 09/30/23 | FY 09/30/22 | FY 09/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $65.3 | $67.6 | $79.2 | $86.2 | $97.1 |
| Operating income | -$85.3 | -$121.7 | -$137.2 | -$123.8 | -$109.6 |
| Net income | -$81.9 | -$116.0 | -$133.8 | -$121.8 | -$79.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$32.2 | -$96.7 | -$112.2 | -$86.9 | -$70.7 |
Shares outstanding 29.1M · Free float 76.1%
Annual filing data through FY ended September 30, 2025; float as of October 10, 2026.